Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Notes Payables (2021 - 2025)

IM Cannabis has reported Notes Payables over the past 5 years, most recently at $10.3 million for Q4 2025.

  • Quarterly results put Notes Payables at $10.3 million for Q4 2025, down 5.2% from a year ago — trailing twelve months through Dec 2025 was $10.3 million (down 5.2% YoY), and the annual figure for FY2025 was $10.3 million, down 7.26%.
  • Notes Payables for Q4 2025 was $10.3 million at IM Cannabis, down from $10.8 million in the prior quarter.
  • Over the last five years, Notes Payables for IMCC hit a ceiling of $10.8 million in Q4 2024 and a floor of $6.8 million in Q4 2022.
  • Median Notes Payables over the past 5 years was $8.9 million (2023), compared with a mean of $8.7 million.
  • Biggest five-year swings in Notes Payables: surged 30.69% in 2023 and later decreased 5.2% in 2025.
  • IM Cannabis' Notes Payables stood at $6.9 million in 2021, then fell by 1.13% to $6.8 million in 2022, then soared by 30.69% to $8.9 million in 2023, then increased by 21.79% to $10.8 million in 2024, then decreased by 5.2% to $10.3 million in 2025.
  • The last three reported values for Notes Payables were $10.3 million (Q4 2025), $10.8 million (Q4 2024), and $8.9 million (Q4 2023) per Business Quant data.